ArticleCancer research communications2022

Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas.

Anne W J Martens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.